Merck Selects Reval for Financial Risk Management

Merck, a global healthcare company, has selected Reval’s software-as-a-service (SaaS) solution to support its foreign exchange (FX) and interest rate derivative portfolios. Merck and Schering-Plough merged in November 2009 to create a new company that today is the second-largest healthcare company in the world.

“We are thrilled to work with such a quality, global company on its initiative to bring together all of its processes for exposure management, derivative management and hedge accounting onto a single, integrated workflow using Reval,” said Jeff Stacey, Reval’s managing director, Americas.


Related reading